| 16.54 0.4 (2.48%) | 01-09 13:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 20.8 | 1-year : | 24.29 |
| Resists | First : | 17.8 | Second : | 20.8 |
| Pivot price | 16.07 |
|||
| Supports | First : | 15.64 |
Second : | 14.3 |
| MAs | MA(5) : | 16.48 |
MA(20) : | 16.01 |
| MA(100) : | 16.55 |
MA(250) : | 23.87 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 64.8 |
D(3) : | 65.3 |
| RSI | RSI(14): 55.8 |
|||
| 52-week | High : | 50 | Low : | 13.6 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MRNY ] has closed below upper band by 33.2%. Bollinger Bands are 28.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.84 - 16.93 | 16.93 - 16.98 |
| Low: | 15.94 - 16.05 | 16.05 - 16.12 |
| Close: | 15.98 - 16.15 | 16.15 - 16.25 |
The fund advisor will employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will take temporary defensive positions during such periods. The fund is non-diversified.
Wed, 24 Dec 2025
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs - The Manila Times
Wed, 26 Nov 2025
YieldMax to execute reverse stock splits of 15 option income strategy funds - MSN
Wed, 26 Nov 2025
YieldMax MRNA Option Income Strategy ETF To Go Ex-Dividend On November 28th, 2025 With 0.0232 USD Dividend Per Share - 富途牛牛
Wed, 08 Oct 2025
YieldMax® ETFs Announces Distributions on BABO, MARO, ULTY, MRNY, SLTY and Others - The Manila Times
Thu, 02 Oct 2025
These 50%+ “AI Dividends” Could Ruin Your Retirement - Contrarian Outlook
Wed, 24 Sep 2025
Moderna: Maintaining Sell Despite Consolidation - And Why MRNY Won't Help Either - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|